UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Hormone and metabolic research, 2012-09, Vol.44 (9), p.694

2012

Volltextzugriff (PDF)

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study

Clinical endocrinology (Oxford), 2014-06, Vol.80 (6), p.884-889

2014

Volltextzugriff (PDF)

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

Journal of endocrinological investigation, 2013-07, Vol.36 (7), p.460-465

2013

Volltextzugriff (PDF)

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials

BMJ open, 2014-10, Vol.4 (10), p.e005708-e005708

2014

Volltextzugriff (PDF)

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

Fertility and sterility, 2017-03, Vol.107 (3), p.788-795.e2

2017

Volltextzugriff (PDF)

Significantly Higher Adrenocorticotropin-Stimulated Cortisol and 17-Hydroxyprogesterone Levels in 337 Consecutive, Premenopausal, Caucasian, Hirsute Patients Compared with Healthy Controls

The journal of clinical endocrinology and metabolism, 2005-03, Vol.90 (3), p.1347-1353

2005

Volltextzugriff (PDF)

Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden

Human reproduction (Oxford), 2024-08, Vol.39 (8), p.1823-1834

2024

Volltextzugriff (PDF)

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

Human reproduction (Oxford), 2014-08, Vol.29 (8), p.1773-1779

2014

Volltextzugriff (PDF)

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS

Human reproduction (Oxford), 2017-11, Vol.32 (11), p.2279-2286

2017

Volltextzugriff (PDF)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Human reproduction (Oxford), 2016-12, Vol.31 (12), p.2791-2795

2016

Volltextzugriff (PDF)

Higher blood pressure in normal weight women with PCOS compared to controls

Endocrine Connections, 2021-02, Vol.10 (2), p.154-163

2021

Volltextzugriff (PDF)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Human reproduction (Oxford), 2017-04, Vol.32 (4), p.966-966

2017

Volltextzugriff (PDF)

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss

Minerva endocrinologica, 2013-03, Vol.38 (1), p.59

2013

Volltextzugriff (PDF)

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

Fertility and sterility, 2004-12, Vol.82 (6), p.1570-1579

2004

Volltextzugriff (PDF)

Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism

Clinical endocrinology (Oxford), 2005-06, Vol.62 (6), p.683-691

2005

Volltextzugriff (PDF)

The Effect of Menopause on Carotid Artery Remodeling, Insulin Sensitivity, and Plasma Adiponectin in Healthy Women

American journal of hypertension, 2009-04, Vol.22 (4), p.364-370

2009

Volltextzugriff (PDF)

Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma

Research and reports in urology, 2017-01, Vol.9, p.113-119

2017

Volltextzugriff (PDF)

Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome

The journal of clinical endocrinology and metabolism, 2005-10, Vol.90 (10), p.5605-5612

2005

Volltextzugriff (PDF)

e-Dietician in General Practice

2010 Second International Conference on eHealth, Telemedicine, and Social Medicine, 2010, p.29-32

2010

Volltextzugriff (PDF)

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.820

2023

Volltextzugriff (PDF)

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.647-658

2023

Volltextzugriff (PDF)

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

Rheumatology (Oxford, England), 2021, Vol.60 (8), p.3635-3645

2021

Volltextzugriff (PDF)

The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

Rheumatology (Oxford, England), 2022-08, Vol.61 (9), p.3647-3656

2022

Volltextzugriff (PDF)

Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

Rheumatology (Oxford, England), 2022-11, Vol.61 (11), p.4286-4296

2022

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

Significantly Higher Adrenocorticotropin-Stimulated Cortisol and 17-Hydroxyprogesterone Levels in 337 Consecutive, Premenopausal, Caucasian, Hirsute Patients Compared with Healthy Controls

Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Higher blood pressure in normal weight women with PCOS compared to controls

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism

The Effect of Menopause on Carotid Artery Remodeling, Insulin Sensitivity, and Plasma Adiponectin in Healthy Women

Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma

Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome

e-Dietician in General Practice

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

Aktive Filter

Suchergebnisse filtern